Experiments in hamsters infected with the SARS-CoV-2 revealed that the virus left residual genetic material in touch-sensing neurons.

The findings rule out the development of autoantibody or excessive anti-SARS-COV-2 antibodies in mediating the disease.

The subtype called IgG4 begins to accumulate late after the second round of SARS-CoV-2 mRNA vaccination.

For illuminating factors that underlie varied susceptibility to COVID-19, Paul Bastard is the grand prize winner of the inaugural Michelson Philanthropies & Science Prize for Immunology.

Vaccinated individuals and those who recovered from severe COVID-19 may be at lower risk for subsequent severe infections with SARS-CoV-2 variants than people who had milder cases.

Underrepresented researchers have been disproportionately affected because many already struggled with inequalities and professional obstacles before COVID-19.

An extraordinary year of vaccine science offers hope that the U.S. can return to something resembling normal life by the end of 2021, said Fauci at the AAAS Annual Meeting.

The virus that causes COVID-19 may enter and replicate in human cells by exploiting newly-identified strings of amino acids.